$3.00

0.00 (0.00%)
Live
Previous Close

$3

Day Range

$2.96 - $3.08

Previous Day Range

$2.9101 - $3.13

Market Cap

$41.9 million USD

Day Vol.

10180

Previous Day Vol.

42343

Currency

USD

Primary Exchange

None

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Here is how Alcon (ALC) and CalciMedica Inc. (CALC) have performed compared to their sector so far this year.

Related tickers: ALC, CALC.

Read Full Article

The Dow Jones index closed lower by around 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. CalciMedica The Trade: CalciMedica, Inc. (NASDAQ: CALC) Chief Business Officer Eric W Roberts acquired a total of 4,000 shares an average price of $3.90. To acquire these shares, it cost around $15,600. What’s Happening: On March 28, CalciMedica posted a fourth-quarter loss of 23 cents ...

Related tickers: RCG, CALC, TGEN.

Read Full Article
Trending Tickers

Please sign in to view